Phenotypic properties of transmitted founder HIV-1 - Wikidata - wikimedia - TriplyDB

Phenotypic properties of transmitted founder HIV-1

Phenotypic properties of transmitted founder HIV-1

http://www.wikidata.org/entity/Q34336058

about

Hybrid spreading mechanisms and T cell activation shape the dynamics of HIV-1 infection HIV-Host Interactions: Implications for Vaccine Design Blocking HIV-1 transmission in the female reproductive tract: from microbicide development to exploring local antiviral responses Origin of the transmitted virus in HIV infection: infected cells versus cell-free virus A Small Molecule, Which Competes with MAdCAM-1, Activates Integrin α4β7 and Fails to Prevent Mucosal Transmission of SHIV-SF162P3 SAMHD1 Limits HIV-1 Antigen Presentation by Monocyte-Derived Dendritic Cells.Bioinformatic analysis of HIV-1 entry and pathogenesis.Are T cells the only HIV-1 reservoir?Bottlenecks in HIV-1 transmission: insights from the study of founder viruses The root extract of the medicinal plant Pelargonium sidoides is a potent HIV-1 attachment inhibitor The genealogical population dynamics of HIV-1 in a large transmission chain: bridging within and among host evolutionary rates Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus Cellular superspreaders: an epidemiological perspective on HIV infection inside the body Recent Insights into the HIV/AIDS Pandemic.Survivors Remorse: antibody-mediated protection against HIV-1.Activities of transmitted/founder and chronic clade B HIV-1 Vpu and a C-terminal polymorphism specifically affecting virion release Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?Pandemic HIV-1 Vpu overcomes intrinsic herd immunity mediated by tetherin.A Naturally Occurring rev1-vpu Fusion Gene Does Not Confer a Fitness Advantage to HIV-1.Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance.HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual.Induction of a Tier-1-like Phenotype in Diverse Tier-2 Isolates by Agents that Guide HIV-1 Env to Perturbation-sensitive, Non-native States.Lessons from acute HIV infection.Optical trapping of individual human immunodeficiency viruses in culture fluid reveals heterogeneity with single-molecule resolution.Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand.Using HIV Sequence and Epidemiologic Data to Assess the Effect of Self-referral Testing for Acute HIV Infection on Incident Diagnoses in San Diego, California Factors associated with siman immunodeficiency virus transmission in a natural African nonhuman primate host in the wild.Antigenicity-defined conformations of an extremely neutralization-resistant HIV-1 envelope spike.Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters.Vaginal myeloid dendritic cells transmit founder HIV-1.New directions for HIV vaccine development from animal models.Which Antibody Functions are Important for an HIV Vaccine?Cross-reactive potential of human T-lymphocyte responses in HIV-1 infection Host and viral determinants of Mx2 antiretroviral activity Virulence and pathogenesis of HIV-1 infection: an evolutionary perspective Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramide.Broadly neutralizing antibody VRC01 prevents HIV-1 transmission from plasmacytoid dendritic cells to CD4 T lymphocytes.Defining differential genetic signatures in CXCR4- and the CCR5-utilizing HIV-1 co-linear sequences.Mucosal immunity in the female genital tract, HIV/AIDS Profile of Beatrice H. Hahn.

P2860

Q21092519-062F9191-77DA-4169-862E-5922C4122A5B Q26765966-8D4D4F75-ED2A-42D3-A8F7-B98188388DD3 Q26774878-79533896-2B75-440E-84D3-3495AA4166FA Q27021279-98C447F7-72F6-41AD-B3BF-D1061480F9D9 Q27313287-7AF8FD99-C426-44A2-9648-1E94E85F82B9 Q27321665-49067F39-3AC2-4927-8593-A2F8104F6D30 Q27693321-F4A3DD1E-D8A7-4F3A-965C-AB735606E32E Q28078850-2FC54B82-EF47-4FAA-8B0C-60C18F6F190A Q28082862-AF189040-6697-4066-B504-6B604C57BF20 Q28539308-AF99C598-0528-412E-9D28-66F8DCD4ED2A Q28541827-1E8AA1FE-941D-4AF0-990F-33B376B7BBC6 Q28551914-D1C0E22A-DBCF-42F5-AD7B-4505EF4403D7 Q28657772-617A905D-E754-452E-B166-91D1A393CE39 Q30235024-06F7A530-EF17-4DC4-A2D7-B5534D916A91 Q30238730-CF6600DF-098E-4D62-A987-D651644AE905 Q30359547-CB8144D5-5AF9-4E74-B4D3-0BE3106274CD Q30362489-580A4920-AD5E-4AF2-B1B6-2E96B3C6D044 Q30376824-F2A25980-30F2-4D5E-9E91-E5D4568C720B Q30381208-0324A2E4-9941-4F2F-A314-8AD5779C6929 Q30391895-CBFE9265-8EC8-43B1-A2DD-71B54DF5511F Q30393763-5FE52295-F590-4DE2-844D-537EFF2010E6 Q30401836-8456DBEF-4634-4462-B867-E170E6FBF54C Q30490195-9B5A97E3-038A-42FC-80E2-E72863E27FBA Q30586117-8C17E0FA-4A79-4730-B7E0-A0318D7A2773 Q30828875-F96CDBCC-B327-49CE-861C-019A3E871F1A Q31095800-D52AFF17-32EC-414A-862F-B8BC5B3D9EBA Q33602718-734FB04E-6250-4B70-AC0D-31A032DF6C60 Q33620194-752FE04E-DFE4-4DBD-91A9-D71DC94296A0 Q33638320-79FD4070-15B3-4B87-A9C2-555415173697 Q33744037-D48759BF-03B5-491E-ACCC-A92060809C86 Q33767191-58C91162-85AE-47AD-84AF-1A992B2189C0 Q33772637-F1DD36E7-FF5A-4B92-85DD-F4ED36BBC33A Q33855306-6DBED9D2-4A90-4D01-9282-952034D0FE37 Q33900299-4A7A5836-5B34-4385-A15B-A28AEDCCE234 Q34040248-D475CBFF-4213-40F7-B6C3-C8A2E66219DE Q34059103-C841E218-3E90-472E-9368-25B1AB0CB3B2 Q34262089-5CB69727-B76C-4677-ABCA-0852619CB555 Q34267043-907D2F47-7E7C-463B-AA03-E0E1FEB1E2CE Q34275424-8ADEABE2-9CC9-41AF-8624-B353354ED6CA Q34339526-6B59633F-D3BB-4B9F-8543-EB4569C891E1

P2860

Phenotypic properties of transmitted founder HIV-1

http://www.wikidata.org/entity/Q34336058

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Phenotypic properties of transmitted founder HIV-1

@ast

Phenotypic properties of transmitted founder HIV-1

@en

Phenotypic properties of transmitted founder HIV-1

@nl

type

label

Phenotypic properties of transmitted founder HIV-1

@ast

Phenotypic properties of transmitted founder HIV-1

@en

Phenotypic properties of transmitted founder HIV-1

@nl

prefLabel

Phenotypic properties of transmitted founder HIV-1

@ast

Phenotypic properties of transmitted founder HIV-1

@en

Phenotypic properties of transmitted founder HIV-1

@nl

P1433

Q34336058-69367B7D-92FA-4941-B921-150EDCDF4F95

P1476

Q34336058-2C78EB3A-A381-4168-8ACC-E3E39DFB0E96

P2093

Q34336058-019F0D2A-DB89-45AD-AC4A-8A1758E60E2A

Q34336058-03D04A5F-CF53-4BC8-A779-0B85E1AA7397

Q34336058-093BF60A-85D0-4943-AB11-FAC7DBE6E81B

Q34336058-09E5476A-E339-4677-B7DE-C9BAD4D33964

Q34336058-0C196D1F-BA60-4BD4-9096-97B1CA2C5336

Q34336058-1B0D5A1D-A424-400E-8ADA-46C6386A63CC

Q34336058-1BD3FA94-A600-4295-99E2-50ABEEB84FEC

Q34336058-1F3B592D-1D5C-4BC2-B31D-F8262DF9F30C

Q34336058-374A0F3A-EBB5-4381-9C55-E66BA44D0FD4

Q34336058-58BEF051-DAAE-433A-AC95-9B5477034AC7

P2860

Q34336058-00C2C2BE-4435-44A2-A0E5-FB91EE2D905E

Q34336058-02D5A858-0B19-4B46-B082-5C412AFF3AC3

Q34336058-05B6C9BA-7541-4028-8C3A-00A1555C11D3

Q34336058-08B88547-3B6A-4F97-BA83-73678A5E6A1B

Q34336058-09C23319-062D-48AB-89DA-CD1470A46272

Q34336058-09D32284-B256-414D-A080-D02DFA7A7BE3

Q34336058-0BFB0290-0FB6-420A-BA08-AA18B8E87D06

Q34336058-1AFB9223-3C19-4256-92A6-30D6CF7BF248

Q34336058-1C2942DF-9985-40D3-B821-EE23C1DA7DF3

Q34336058-1C66594F-098C-47FB-9FC7-3CD5CBC14003

P304

Q34336058-B85CE80B-826B-425C-BA7A-C4A334BBEE20

P31

Q34336058-83487DB9-B3DF-4470-9822-A32157F93F27

P356

Q34336058-29FF97F8-FB00-411E-8B00-F499EDF26647

P407

Q34336058-DBD170B3-5ADC-4178-8680-339BF0F4E323

P433

Q34336058-0531B2CA-8E91-4FB4-91D5-042EDEDD841E

P478

Q34336058-7E406FCC-902D-45D6-9ACE-814F757D3D93

P50

Q34336058-231B5CDD-1CB3-429E-9314-072950C6E226

Q34336058-306DC972-41A9-4793-8428-E0F4D978B320

Q34336058-52A43322-1580-45F0-9E06-B9B727DF79F8

Q34336058-60C31E79-6DB7-44EC-8C40-2ED71E5ECC8C

Q34336058-82761CEE-D162-4302-A8D6-9DEDDD3DC47B

Q34336058-E4DCE44B-76CD-41E0-9113-57FE75FE6C9B

Q34336058-EABFA34A-620D-4523-ACE3-DDFD541A6384

Q34336058-F296CAA9-45D4-4354-BD7B-237C02BA41F1

Q34336058-F400C371-E9BF-4D46-AA64-D6F4FBA592B9

Q34336058-F53E51FA-ED48-4E83-8E15-E6E3C4D329C2

P577

Q34336058-D193F0FF-CA3A-432C-AC41-79BD48DF49D4

P5875

Q34336058-E5AC1B2F-D1C2-43B8-9CC2-415E54A1BAFC

P698

Q34336058-F3A815D3-2DA1-4F89-86C4-B603A5DF4A99

P921

Q34336058-F4B3088C-FAD3-4815-9561-347212C7065A

P932

Q34336058-1EC7E6E9-FBAE-4E41-8543-82EB7DB1FD5B

P356

PNAS.1304288110

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Phenotypic properties of transmitted founder HIV-1

@en

P2093

Amit Kumar

http://www.w3.org/2001/XMLSchema#string

Anna Berg

http://www.w3.org/2001/XMLSchema#string

Anthony P West

http://www.w3.org/2001/XMLSchema#string

Bhavna Hora

http://www.w3.org/2001/XMLSchema#string

Christina Ochsenbauer

http://www.w3.org/2001/XMLSchema#string

Elena E Giorgi

http://www.w3.org/2001/XMLSchema#string

Erica H Parrish

http://www.w3.org/2001/XMLSchema#string

Fangping Cai

http://www.w3.org/2001/XMLSchema#string

Feng Gao

http://www.w3.org/2001/XMLSchema#string

Haitao Ding

http://www.w3.org/2001/XMLSchema#string

P2860

Few and far between: how HIV may be evading antibody avidity

The interferon response inhibits HIV particle production by induction of TRIM22

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

A diverse range of gene products are effectors of the type I interferon antiviral response

Env length and N-linked glycosylation following transmission of human immunodeficiency virus Type 1 subtype B viruses

Resistance to alpha/beta interferons correlates with the epizootic and virulence potential of Venezuelan equine encephalitis viruses and is determined by the 5' noncoding region and glycoproteins

Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

Diversity of receptors binding HIV on dendritic cell subsets

P304

6626-6633

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1304288110

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P50

Pamela J. Bjorkman

Persephone Borrow

Beatrice H. Hahn

Nicholas F Parrish

P577

2013-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236093711

http://www.w3.org/2001/XMLSchema#string

P698

23542380

http://www.w3.org/2001/XMLSchema#string

P921

HIV transmission

P932

3637789

http://www.w3.org/2001/XMLSchema#string